Abstract:Laryngeal squamous cell carcinoma (LSCC) and hypopharyngeal squamous cell carcinoma (HPSCC) are two types of head and neck cancers with high incidence rates and relatively poor prognoses. The aim of the present study was to determine the effects of microRNA (miR/miRNA)-136-5p and its downstream target, Rho-associated coiled-coil containing protein kinase 1 (ROCK1), on LSCC and HPSCC progression and cisplatin sensitivity. The miRNA and protein expression levels in head and neck cancer cell lines were evaluated using reverse transcription-quantitative PCR and western blotting, respectively. MTT, wound healing assays, transwell assays and flow cytometry analysis were performed to measure cell properties. The binding between miR-136-5p and ROCK1 was detected using a dual-luciferase reporter assay. Autophagy double-labeled adenoviral infection assays were used to assess cell autophagy. The results showed that miR-136-5p was expressed in LSCC and HPSCC cells. Functional experiments showed that the expression of miR-136-5p in LSCC and HPSCC cells was negatively correlated with cell viability, invasion and migration. Additionally, miR-136-5p overexpression inhibited epithelial-mesenchymal transition, whereas miR-136-5p knockdown had the opposite effect. Dual-luciferase reporter assays confirmed the targeting relationship between miR-136-5p and ROCK1. miR-136-5p overexpression increased the cisplatin sensitivity of LSCC and HPSCC cells by reducing cell viability, as well as promoting cell apoptosis and autophagy. miR-136-5p overexpression decreased the expression levels of its downstream target ROCK1 and attenuated activity of the Akt/mTOR signaling pathway in cisplatin-treated LSCC and HPSCC cells. Conversely, miR-136-5p knockdown increased ROCK1 levels and decreased cisplatin sensitivity of the LSCC and HPSCC cells by increasing cell viability and inhibiting cell apoptosis, which was reversed by ROCK1 inhibition using the ROCK1 inhibitor, Y27632. Taken together, the results showed that the miR-136-5p/ROCK1 axis inhibits cell invasion and migration, and increases the sensitivity of LSCC and HPSCC cells to cisplatin.

Lncrna-Cche1 is Involved in Migration and Invasion but Not in Proliferation of Pancreatic Adenocarcinoma Cells Possibly by Interacting with ROCK1.

LncRNA UCA1 Promotes Migration and Invasion in Pancreatic Cancer Cells Via the Hippo Pathway

LINC00346 Promotes Pancreatic Cancer Progression Through the CTCF-mediated Myc Transcription

Long Non-Coding RNA DSCAM-AS1 Promotes Pancreatic Cancer Progression Via Regulating the Mir-136-5p/pbx3 Axis

Long Noncoding RNA CCHE1 Indicates a Poor Prognosis of Hepatocellular Carcinoma and Promotes Carcinogenesis Via Activation of the ERK/MAPK Pathway.

Overlapping and Unique Roles Played by ROCK1 and 2 in the Modulation of Coding and Long Noncoding RNA Expression

Long noncoding RNA LINC00941 promotes pancreatic cancer progression by competitively binding miR-335-5p to regulate ROCK1-mediated LIMK1/Cofilin-1 signaling

Cervical Carcinoma High-Expressed Long Non-Coding RNA 1 May Promote Growth of Colon Adenocarcinoma Through Interleukin-17A

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

LncRNA AC100826.1 regulated PLCB1 to promote progression in non‐small cell lung cancer

Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression

The Mir-136-5p/rock1 Axis Suppresses Invasion and Migration, and Enhances Cisplatin Sensitivity in Head and Neck Cancer Cells.

LncRNA CCAT1 Participates in Pancreatic Ductal Adenocarcinoma Progression by Forming a Positive Feedback Loop with C-Myc.

Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma

Effect of H3K27 Acetylation Activated-Long Noncoding RNA CCAT1 on Cell Proliferation and Migration by Regulating SPRY4 and HOXB13 Expression in Esophageal Squamous Carcinoma Cell.

The C/Ebp Beta-Linc01133 Axis Promotes Cell Proliferation In Pancreatic Ductal Adenocarcinoma Through Upregulation Of Ccng1

LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing Mir-152.

Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells.

The Lncrna ENSG00000254041.1 Promotes Cell Invasiveness and Associates with Poor Prognosis of Pancreatic Ductal Adenocarcinoma.

LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2

CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer.